KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 103 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $7,681,000 | +36.6% | 101,989 | -9.0% | 0.44% | +36.6% |
| Q1 2015 | $5,621,000 | +64.7% | 112,080 | +13.9% | 0.32% | +57.0% |
| Q4 2014 | $3,412,000 | +56.7% | 98,378 | +48.0% | 0.21% | +36.2% |
| Q3 2014 | $2,178,000 | +99.8% | 66,486 | +134.0% | 0.15% | +108.2% |
| Q2 2014 | $1,090,000 | +17.3% | 28,416 | +21.6% | 0.07% | +7.4% |
| Q1 2014 | $929,000 | – | 23,365 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 48,087 | $1,575,000 | 4.91% |
| Palo Alto Investors LP | 1,102,181 | $36,107,000 | 2.70% |
| Aureus Asset Management, LLC | 139,092 | $4,557,000 | 1.14% |
| Redmile Group, LLC | 281,479 | $9,221,000 | 1.06% |
| PFM Health Sciences, LP | 978,752 | $32,064,000 | 0.74% |
| SENZAR ASSET MANAGEMENT, LLC | 66,300 | $2,172,000 | 0.64% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $5,781,000 | 0.54% |
| Polar Capital LLP | 479,967 | $15,724,000 | 0.33% |
| Partner Investment Management, L.P. | 22,443 | $735,000 | 0.27% |
| Old West Investment Management, LLC | 10,408 | $340,000 | 0.21% |